Judo athlete reprimanded for presence of prohibited stimulant
(Ottawa, Ontario – November 18, 2013) – The Canadian Centre for Ethics in Sport (CCES) announced today that a judo athlete has committed an anti-doping rule violation and has received a sanction of a reprimand. The athlete’s urine sample, collected during in-competition doping control on July 7, 2013, revealed the presence of methylphenidate, a prohibited stimulant.
Methylphenidate is classified as a “specific substance” on the World Anti-Doping Agency Prohibited List, banned in-competition. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek a sanction reduction from two years of ineligibility down to a reprimand. Based on factors assessed, including the athlete's degree of fault, the CCES proposed a sanction of a reprimand and no period of ineligibility.
In response to the CCES’ notification of the adverse analytical finding, the athlete waived his right to a hearing, acknowledged the anti-doping rule violation, and accepted the sanction of a reprimand proposed by the CCES.
The Canadian Centre for Ethics in Sport is an independent, national, not-for profit organization. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.
- Intelligence-based anti-doping efforts in Canada receive a major boost in funding
- Proportionality in doping cases and proposed revisions to the World Anti-Doping Code
- US Paralympic cycling athlete, Morelli, accepts sanction for rule violation
- Briton Sir Craig Reedie elected World Anti-Doping Agency President